Description
Tirzepatide is a synthetic peptide engineered to interact with both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor pathways. FDA records classify tirzepatide as both a GIP receptor agonist and a GLP-1 receptor agonist, making its dual-receptor structure particularly relevant to controlled metabolic and cellular signaling studies.
Tirzepatide peptide research may examine receptor activation, glucose-related signaling, energy regulation, metabolic pathways, and interactions between GIP and GLP-1 signaling systems. The compound’s defined molecular structure provides researchers with a useful model for studying how dual incretin-receptor activity influences biological responses in experimental settings.
Features
- Composition: Synthetic peptide with dual GIP and GLP-1 receptor activity
- CAS Number: 2023788-19-2
- Molecular Formula: Approximately C225H347N49O66
- Molecular Weight: Approximately 4,813 Da
- Alternative Research Name: LY3298176
- Format: Supplied as lyophilized powder
- Research Focus: Incretin signaling, metabolic regulation, receptor activity, and glucose-related pathways
- Tirzepatide purity testing may use analytical methods such as HPLC to assess sample composition and purity
- Tirzepatide purity should be referenced against the product’s current batch-specific Certificate of Analysis, where available
- Recommended Storage: −20 °C
Disclaimer: Supplied strictly for laboratory research. Not intended for human or veterinary use, administration, consumption, diagnosis, treatment, or therapeutic purposes.
Reviews
There are no reviews yet.